122 results
Page 3 of 7
6-K
EX-99.3
9zotk162ayf3hf5
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.4
cj1u4
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.5
rtqhfnn
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.2
1c7ssmqodbrk yeq6n0l
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.1
y3v4zng n7b2v
16 Nov 22
XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer
7:29am
424B3
21aasc2 8p627i537
14 Nov 22
Prospectus supplement
1:51pm
6-K
EX-99.3
ftsqj u6s
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
6-K
EX-99.4
559ll1w68
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
6-K
EX-99.2
qssluox ib5ll5
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
S-8
EX-4.2
e64zn9xdkqu2d8g 15
27 Oct 22
Registration of securities for employees
7:09pm
424B4
jfb z6dxp32h3he55kz
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
snawcq7nu500k9
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
anfpu5iqwiic wqo
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1/A
EX-10.14
3emc83y892 djl5kjm9g
9 Sep 22
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.2
ak75c6
9 Sep 22
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.3
5rqf0xq vnu7sabuj3r
9 Sep 22
Registration statement (foreign) (amended)
9:34pm
F-1
rc8mva9by5tpbetdgv
8 Sep 22
Registration statement (foreign)
1:02pm
UPLOAD
qi4kpx lq5ngdix
16 Aug 22
Letter from SEC
12:00am
DRS
miv4hm1b5e3
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
nx9q yviq19srqkng1
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am